MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

Search

Cerus Corp

Fechado

SetorSaúde

1.61 5.92

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.52

Máximo

1.63

Indicadores-chave

By Trading Economics

Rendimento

2M

-5.7M

Vendas

9.2M

52M

Margem de lucro

-10.897

Funcionários

614

EBITDA

2.7M

-3.1M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+194.12% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

51M

299M

Abertura anterior

-4.31

Fecho anterior

1.61

Sentimento de Notícias

By Acuity

67%

33%

321 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Cerus Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de out. de 2025, 20:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil Agrees to NZ$437.7 Million Deal to Raise Contact Energy Stake

19 de out. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Lower Amid Signs of U.S.-China Trade Tensions Easing -- Market Talk

19 de out. de 2025, 23:37 UTC

Conversa de Mercado

New Zealand's Core CPI Keeps Rate Cut Hopes Alive -- Market Talk

19 de out. de 2025, 23:36 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street Gains -- Market Talk

19 de out. de 2025, 23:36 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de out. de 2025, 23:09 UTC

Conversa de Mercado

Could Rio Tinto, BHP Ally to Defend Iron-Ore Pricing Power? -- Market Talk

19 de out. de 2025, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Luxury Fashion House Kering Confirms Beauty Deal With L'Oréal -- Barrons.com

19 de out. de 2025, 22:30 UTC

Ganhos

Stock Futures Rise Ahead of Major Week of Earnings -- Barrons.com

19 de out. de 2025, 22:18 UTC

Conversa de Mercado

Gold at $5,000 on Cards as Investors Get Comfortable -- Market Talk

19 de out. de 2025, 21:50 UTC

Conversa de Mercado

Infratil's Contact Stake Buy May Require Bigger Asset Sales -- Market Talk

19 de out. de 2025, 21:15 UTC

Conversa de Mercado

Investors Need to Change Narrative Toward Scales -- Market Talk

19 de out. de 2025, 19:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil's Contact Shareholding to Rise to 14.3% When Deal Completes

19 de out. de 2025, 19:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil to Issue New Shares Worth NZ$218.8 Million to TECT at NZ$12.43 Each

19 de out. de 2025, 19:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil Part-Funding Purchase of Contact Energy Stake With NZ$218.8 Million of Existing Debt

19 de out. de 2025, 19:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil Acquiring Additional Contact Energy Stake for NZ$8.95/Share

19 de out. de 2025, 19:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil Acquiring Contact Energy Stake for NZ$437.7 Million

19 de out. de 2025, 19:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil Acquiring TECT Holdings's Shareholding in Contact Energy

19 de out. de 2025, 19:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Infratil to Acquire Additional 4.92% Stake in Contact Energy

19 de out. de 2025, 16:29 UTC

Ganhos

Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings -- Barrons.com

19 de out. de 2025, 11:14 UTC

Ganhos

Zijin Mining 3Q Oper Income CNY86.49B; up 8.1% on Year>2899.HK

19 de out. de 2025, 11:14 UTC

Ganhos

Zijin Mining: Higher Sales of Gold, Copper Supported Results >2899.HK

19 de out. de 2025, 11:14 UTC

Ganhos

Zijin Mining 3Q Net CNY14.57B; up 57.1% on Year>2899.HK

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 de out. de 2025, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

17 de out. de 2025, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 de out. de 2025, 22:15 UTC

Conversa de Mercado

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 de out. de 2025, 21:15 UTC

Conversa de Mercado

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

Comparação entre Pares

Variação de preço

Cerus Corp Previsão

Preço-alvo

By TipRanks

194.12% parte superior

Previsão para 12 meses

Média 4.5 USD  194.12%

Máximo 5 USD

Mínimo 4 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Cerus Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.3 / 1.36Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

321 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
help-icon Live chat